Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthc

Prestige Brand Holdings is recalling 39,060 bottles of certain Clear Eyes drops over sterility conce

Amylyx Pharmaceuticals, Inc. is upgraded to Strong Buy after positive phase 3 LUCIDITY results for a

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consum

Premium Brands TSE: PBH said its revised 2026 outlook reflects timing shifts in U.S. customer progra

California State Teachers Retirement System boosted its holdings in shares of Prestige Consumer Heal

Prestige Consumer Healthcare NYSE: PBH reported first-quarter fiscal 2027 revenue growth of 6.5%, su

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $0.98 per share, beating the

Prestige Consumer (NYSE:PBH) raises FY2027 Adj EPS guidance from $4.42-$4.51 to $4.55-$4.65 vs $4.53

Prestige Consumer (NYSE:PBH) reported quarterly earnings of $0.98 per share which beat the analyst c

TARRYTOWN, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) toda

Bank of New York Mellon Corp cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:

Dimensional Fund Advisors LP increased its holdings in shares of Prestige Consumer Healthcare Inc. (

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quar

Fifth Third Bancorp boosted its position in Prestige Consumer Healthcare Inc. (NYSE: PBH) by 8,130.0

Bessemer Group Inc. raised its holdings in Prestige Consumer Healthcare Inc. (NYSE: PBH) by 20.9% du

On June 30, 2026, John Rogers (Trades, Portfolio) executed a notable transaction involving Prestige

Investors need to pay close attention to PBH stock based on the movements in the options market late

TARRYTOWN, N.Y., July 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Pr

This under-the-radar healthcare stock just made its biggest acquisition ever -- and it could easily

TARRYTOWN, N.Y., June 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (th

Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lo

Prestige Consumer (NYSE:PBH) is looking for FY2027 Adj EPS of $4.42-$4.51 vs $4.79 analyst estimate.

Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.23 per share which missed the analyst

Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lo

Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portf

Prestige Consumer (NYSE:PBH) narrows FY2026 Adj EPS guidance from $4.54-$4.58 to $4.54 vs $4.55 anal

Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.14 per share which met the analyst co

Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lo

Updated Fiscal 2026 Outlook"Looking ahead, for the full year, we remain committed to rebuilding

Jefferies analyst Keith Devas maintains Prestige Consumer (NYSE:PBH) with a Hold and lowers the p

Adhishthana.com Analysis: Prestige Consumer Healthcare's chart shows a bearish setup after a Cak

Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lo

Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lo

Prestige Consumer (NYSE:PBH) lowers FY2026 GAAP EPS guidance from $4.70-$4.82 to $4.50-$4.58 vs $4.7

Prestige Consumer (NYSE:PBH) reported quarterly earnings of $0.95 per share which missed the analyst